Objective: To explore the effect of treatment of Shenqi Fuzheng Injection combined with XELOX to the patients with gastric cancer.Methods:From Feb 2010 to Jul 2013,186 cases of gastric cancer patients which come to our hospital for treatment were divided into treatment group and control group according to the stratified randomization method,each had 93 cases.The patients of control group were given XELOX chemotherapy and supportive therapy for treatment.The patients of treatment group were given Shenqi Fuzheng Injection on the basis of the treatment of control group.Results:The total efficiency of treatment,tumor progression dead time and 2-year survival rate of treatment group were significantly higher than that of the control group(P<0.05); The 6 months distant metastasis rate 3 (3.23%) of treatment group was significantly lower than the control group 11 (11.83)% (P = 0.026).Conclusion:By using Shenqi Fuzheng Injection combined with XELOX chemotherapy can significantly improve the therapeutic effect,promote cellular immune activity,reducing tumor progression and distant metastasis rate,it also can significantly improve chemotherapy adverse reactions.%目的：探究参芪扶正注射液联合XELOX化疗方案对胃癌患者的治疗效果及预后的影响。方法：选取2010年2月至2013年7月来我院就诊的胃癌患者186例，依据分层随机分组法将患者分为治疗组及对照组各93例，给予对照组常规处理及XELOX化疗方案进行化学治疗；给予治疗组患者对照组治疗方案的基础上联合应用参芪扶正注射液进行治疗。结果：治疗组患者的治疗总有效率、肿瘤进展停滞时间及2年生存率明显高于对照组（P＜0.05）。治疗组患者的6个月远处转移率3（3.23%）明显低于对照组11（11.83）%（P=0.026）。结论：在对胃癌患者进行XELOX化疗方案治疗时联合应用参芪扶正注射液可明显提高治疗效果，促进机体细胞免疫活性的提高，降低肿瘤进展及远处转移率，并能明显改善化疗不良反应情况。
展开▼
